Meningococcal Vaccine Clinical Trial
Official title:
Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.
As part of an effort to increase MenB vaccine uptake among adolescents and young adults, study teams will conduct qualitative research to maximize the effectiveness of nationally recommended MenB educational materials. In this study, Study Teams will assess local barriers to MenB vaccination by conducting focus groups with parents, students, and health care professionals.
Participants (parents of 16-23 year old teens and young adults, high school and college students 16-23 years old, and health care professionals for 16-23 year olds) will be asked to share their thoughts on the completeness of nationally recommended and publicly available MenB vaccine educational materials in addressing hesitations to receipt of the MenB vaccine. There is no risk in discussing reactions to educational materials. The biggest risk is disclosure of information provided in the study which will be reactions to health-promotion material. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04645966 -
A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants
|
Phase 2 | |
| Completed |
NCT01299480 -
A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years
|
Phase 2 | |
| Completed |
NCT01323270 -
A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.
|
Phase 2 | |
| Completed |
NCT04440176 -
A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules
|
Phase 2 | |
| Completed |
NCT04440163 -
MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age
|
Phase 3 | |
| Completed |
NCT03509051 -
Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation
|
N/A | |
| Completed |
NCT03263403 -
Non Inferiority Trial of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladesh.
|
Phase 2/Phase 3 | |
| Completed |
NCT04893811 -
Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age
|
Phase 4 | |
| Completed |
NCT04819113 -
Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age
|
Phase 3 | |
| Completed |
NCT03135834 -
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.
|
Phase 3 | |
| Completed |
NCT01830855 -
A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years
|
Phase 3 |